|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 欧洲肿瘤内科协会对子宫内膜癌的诊断、治疗和随访所制定的临床实践指南显示文摘目前,子宫内膜癌(简称内膜癌)是欧洲和北美洲最常见的妇科恶性肿瘤。对西欧妇女来说,内膜癌是癌症致死的第7大危险因素,占所有因癌症死亡人数的1%~2%。在欧盟国家每年有81500例妇女患病,而且发病率呈逐渐上升的趋势。 | Plataniotis G Castiglione M 杨华 郎景和 | 2011 | 国际妇产科学杂志2011，38，2： | 7 |
| 2 | Cardiotoxicity of chemothera peuticagents and radiotherapy related heart disease: ESMO Clin- ical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Ann Oncol2010，21，5： | 1 |
| 3 | Combined teletherapy and intracavitary brachythempy boost for the treatment of nasopharyngeal carcinoma 显示文摘 | J Kouvaris G A Plataniotis P'Sandilos | 1996 | Radiother Oncol (S0167-8140)1996，38，3： | 1 |
| 4 | Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer,feasibility and long-term results from a phase Ⅱ randomized trial显示文摘 | Kouloulias V Plataniotis G Kouvaris J | 2005 | Am J Clin Oncol2005，28，1： | 1 |
| 5 | Cardiotoxicity of chemothera- peutic agents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Ann Oncol2010，21，5： | 1 |
| 6 | Cardiotoxicityof chemotherapeutic agents and radiotherapy-related heart disease:ESMO Clinical Prae- tiee Guidelines 显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Ann Oncol2010，21，5： | 1 |
| 7 | Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-coursed vancormycin prophylaxis显示文摘 | VASSILOMNOLAKIS M PLATANIOTIS G KOUMAKIS G | 1995 | BMT1995，15，： | 1 |
| 8 | Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | | 0，，5： | 1 |
| 9 | Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Ann Oncol2010，21，5： | 1 |
| 10 | Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Ann Oncol2010，21，5： | 1 |
| 11 | Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO clinical practice guidelines显示文摘 | D Bovelli G Plataniotis F Roila | 2010 | Ann Oncol2010，21，5： | 1 |
| 12 | Cardiotoxicity of chemotherapeutic a- gents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines 显示文摘 | Bvelli D Plataniotis G Roila F | 2010 | Annals of Oncotogy2010，21，5： | 1 |
| 13 | Cardiotoxicity of chemotherapeutic agents and radiotherapy related heart disease: ESMO Clinical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Ann Oneol2010，21，5： | 1 |
| 14 | Endometrial cancer:ESMO clinical practice guidelines for diagnosis,treatment and follow-up显示文摘 | Plataniotis G Castiglione M ESMO Guidelines Working Group | | 0，，5： | 1 |
| 15 | Endometrial cancer: ESMO Clinical Practice Guide- lines for diagnosis, treatment and follow - up 显示文摘 | Plataniotis G Castiglione M ESMO Guidelines Working Group | 2010 | Ann On- col2010，21，5： | 1 |
| 16 | Cardiotoxicity of chemoth- terapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelnies 显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Ann Oncol2010，215，： | 1 |
| 17 | Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma显示文摘 | Talieri M Papadopoulou S Scorilas A Xynopoulos D Arnogianaki N Plataniotis G | 2004 | Cancer Lett2004，205，1： | 1 |
| 18 | Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | 2010 | Annals of Oncology2010，21，5： | 1 |
| 19 | Radio-chemotherapy for bladder cancer: Contribution of chemotherapy on local control显示文摘The purpose of this study was to review the magnitude of contribution of chemotherapy(CT) in the local control of muscle invasive bladder carcinoma in the studies where a combined radio-chemotherapy(RCT) was used(how much higher local control rates are obtained with RCT compared to RT alone).Studies on radiotherapy(RT) and combined RCT,neo-adjuvant,concurrent,adjuvant or combinations,reported after 1990 were reviewed.The mean complete response(CR) rates were significantly higher for the RCT studies compared to RT-alone studies:75.9% vs 64.4%(Wilcoxon ranksum test,P = 0.001).Eleven of the included RCT studies involved 2-3 cycles of neo-adjuvant CT,in addition to concurrent RCT.The RCT studies included the onephase type(where a full dose of RCT was given and then assessment of response and cystectomy for nonresponders followed) and the two-phase types(where an assessment of response was undertaken after an initial RCT course,followed 6 wk later by a consolidation RCT for those patients with a CR).CR rates between the two subgroups of RCT studies were 79.6%(one phase) vs 71.6%(two-phase)(P = 0.015).Theaverage achievable tumour control rates,with an acceptable rate of side effects have been around 70%,which may represent a plateau.Further increase in CR response rates demands for new chemotherapeutic agents,targeted therapies,or modified fractionation in various combinations.Quantification of RT and CT contribution to local control using radiobiological modelling in trial designs would enhance the potential for both improved outcomes and the estimation of the potential gain. | George A Plataniotis Roger G Dale | 2013 | World Journal of Radiology2013，5，8： | 1 |
| 20 | Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO Clinical Practice Guidelines显示文摘 | Bovelli D Plataniotis G Roila F | | 0，，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员